The National Health Commission and 14 other departments recently issued the "2024 Work Points for Correcting Unhealthy Practices in the Field of Pharmaceutical Purchasing and Sales and Medical Services", which requires continuous standardization of the order of pharmaceutical production and circulation, concentrated rectification of unhealthy practices and corruption issues around the people, resolute rectification of industry chaos, practical maintenance of the security of medical insurance funds, and deepening and consolidating the effectiveness of centralized rectification work. Focus on key links and increase disposal efforts. Intensify the governance of commercial bribery in the field of pharmaceutical procurement and sales, closely monitor risks in the pharmaceutical industry where power is concentrated, capital is intensive, and resources are abundant, such as project procurement, catalog preparation, price determination, project application, new drug declaration, and payment settlement. Focus on illegal activities such as issuing false invoices, false transactions, and false activities to embezzle funds for illegal purposes, and maintain a high-pressure crackdown. Strictly investigate illegal and irregular behaviors in bundling sales and "selling with money" through various forms such as fake conferences, donations, scientific research cooperation, and experimental promotion. Optimize internal management and standardize business service behavior. Improve and implement the core medical system to ensure reasonable examination, medication, treatment, and standardized fees for patients during the medical treatment process. Focus on the issue of accepting kickbacks through academic lectures, external testing, prescription dispensing, online medication, and other means, as well as the issue of using one's position to demand and illegally accepting property. Focus on the "two key points" and implement management requirements. Focus on the management of "key minority" and key personnel in medical institutions such as "famous hospitals" and "famous doctors", with a focus on punishing oneself or instructing relatives and friends, using commercial enterprises to "rely on medical treatment", and accepting kickbacks from suppliers; Starting from "platform style lectures" and "dining table style meetings", we will adhere to the "integration of wind and corruption" governance, thoroughly crack down on the behavior of accepting disguised benefits from pharmaceutical enterprises, and deal with it seriously in accordance with laws and regulations such as the Physician Law of the People's Republic of China. Strengthen supervision and law enforcement, and crack down on illegal activities. Strengthen cross departmental joint law enforcement in medical supervision and focus on addressing prominent issues. Continuously maintain efforts to crack down on unqualified institutions and personnel engaged in illegal medical practices. Strictly crack down on illegal drug recycling, "medical care", "drug traffickers" and other illegal and irregular behaviors. Focus on violations of laws and regulations in the fields of assisted reproduction, medical testing, physical examination, medical beauty, Internet medicine, etc., and firmly punish high-voltage lines. Strengthen the supervision of medical insurance funds and maintain a high-pressure situation in cracking down on fraud and insurance fraud. Jointly carry out flight inspections to achieve comprehensive coverage in all provinces and strengthen tracking and supervision of subsequent rectification. Strengthen the management of medical insurance payment qualifications for personnel in designated medical institutions, and explore a mechanism of "supervision to individuals". Deepen the special rectification of illegal and irregular issues in medical insurance funds, rely on the advantages of medical insurance big data screening and analysis, carry out comprehensive supervision such as data sharing, joint law enforcement, line disposal, supervision and supervision, and effectively maintain the safety of medical insurance funds. (Lai Xin She)